05
24
2017
As a one-stop pharmaceutical R & D outsourcing CRO, by providing the information on cardio toxicity assessment in the early period, this could help Medicilon for screening higher cardiac safety factor candidate compound through our chemical, pharmacodynamics, pharmaceutical and preparation services or platforms.
05
09
2017
Medicilon purchased the inhalation exposure system equipment for both big and small animals. This newly bought system comply with OECD requirements which fulfill the single dose and multi-channel inhalation toxicity test requirements for rat, mice, dogs and other animals.We are currently carrying out the pre-experiment and will soon be able to provide the reliable inhalation of drug delivery services to our clients.
04
14
2017
Medicilon has attended a lot of large academic exchange meeting such as SAPA. Collaboration and win-win are our mission as well as our vision of globalization.
11
01
2016
China Pharmaceutical University and Hefei Chaohu Economic Development Zone successfully co-hosted the “2016 Recombinant Protein and Antibody Drug R&D Seminar” at Shenye Holiday Inn Hot Spring Resort recently.
10
26
2016
Biologics are recognized as one of the most promising areas for drug discovery and development in the 21st century.